Resmed Inc (RMD) Wednesday said it has published a meta analysis in The Lancet Respiratory Medicine showing that CPAP therapy significantly reduces the risk of death for people with obstructive sleep apnea (OSA).
This meta analysis collected data from more than 1 million OSA patients across 30 studies. Results from the analysis showed that people who use CPAP (continuous positive airway pressure) therapy have a 37 percent lower risk of dying from any cause compared to those who do not use CPAP. The study also showed that these patients have 55 percent lower risk of dying from cardiovascular disease, supporting CPAPs benefits for heart health in people with OSA.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.